Comparison of 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography (FLT PET) and FDG PET/CT for the detection and characterization of pancreatic tumours
about
Advancement in treatment and diagnosis of pancreatic cancer with radiopharmaceuticalsRepopulation of tumor cells during fractionated radiotherapy and detection methods (Review).FDG-PET in diagnosis, staging and prognosis of pancreatic carcinoma: a meta-analysis.How fibrosis influences imaging and surgical decisions in pancreatic cancer.Surgeons' knowledge regarding the diagnosis and management of pancreatic cancer in China: a cross-sectional study.Single-scan dual-tracer FLT+FDG PET tumor characterization.18F-FLT Positron Emission Tomography/Computed Tomography Imaging in Pancreatic Cancer: Determination of Tumor Proliferative Activity and Comparison with Glycolytic Activity as Measured by 18F-FDG Positron Emission Tomography/Computed Tomography ImagMethodology for quantitative rapid multi-tracer PET tumor characterizationsMolecular imaging for early prediction of response to Sorafenib treatment in sarcoma.Combined Injection of (18)F-Fluorodeoxyglucose and 3'-Deoxy-3'-[(18)F]fluorothymidine PET Achieves More Complete Identification of Viable Lung Cancer Cells in Mice and Patients than Individual Radiopharmaceutical: A Proof-of-Concept Study.The role of stroma in pancreatic cancer: diagnostic and therapeutic implications.Imaging modalities for characterising focal pancreatic lesions.Current clinical status of 18F-FLT PET or PET/CT in digestive and abdominal organ oncology.F-18 fluorodeoxyglucose positron emission tomography for differential diagnosis of pancreatic tumors.3'-Deoxy-3'-¹⁸F-fluorothymidine positron emission tomography as an early predictor of disease progression in patients with advanced and metastatic pancreatic cancer.Mismatched intratumoral distribution of [18F] fluorodeoxyglucose and 3'-deoxy-3'-[18F] fluorothymidine in patients with lung cancer.The role of 18F-fluorodeoxyglucose positron emission tomography in the management of patients with pancreatic adenocarcinoma.A pilot study of the diagnostic and prognostic values of FLT-PET/CT for pancreatic cancer: comparison with FDG-PET/CT.FLT-PET/CT diagnosis of primary and metastatic nodal lesions of gastric cancer: comparison with FDG-PET/CT.
P2860
Q26766690-D4D24CC7-6393-4522-A057-47930D61C3D3Q33727528-85BF1601-EE33-4BB4-A65E-4EEDF4748C7FQ34901401-D90A05CF-6613-4FEA-8C74-7101ACCB7223Q36291856-8EA2398E-DBCA-434D-8EA6-F57DF3E95099Q36397177-1491F044-5A42-4544-8CD4-6A20726CE9F1Q36558260-FC453DC9-AADA-428E-9317-109D31A6C883Q36727598-2C454DBE-E1C4-4117-A7CB-F762AB995C86Q37342653-A98E94A2-BF7E-4F29-B211-95FFBE545A19Q37402623-12C161F7-F383-4C10-9200-F52DF7AC5D2EQ37474422-2602F014-8225-45CE-9914-FF9288D102CBQ38019761-248AD70D-6685-4234-AC27-A2E06F999369Q38834240-B627390E-80B1-4208-AB95-291906ED5F2AQ38988008-B219BE9D-290D-4F54-8095-49A7C76EFE25Q39467787-8DC70C45-2AD9-447B-BE23-589DFD098F49Q41448654-219801AC-F3AC-4DDC-BFB2-EAD8B146ECD2Q47103576-CF6ECC4D-7D8D-467D-A320-873D4032754BQ49391836-6A43B94D-85E7-4C2D-8FC1-699CB811C5CAQ52953650-BEA88599-BD69-40FB-A274-DF9E1EC9D404Q52982567-856B9ADA-8038-429F-95C0-C960910BDFBD
P2860
Comparison of 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography (FLT PET) and FDG PET/CT for the detection and characterization of pancreatic tumours
description
im Januar 2012 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 26 January 2012
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2012
@uk
name
Comparison of 3′-deoxy-3′-[18F ...... rization of pancreatic tumours
@en
Comparison of 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography
@nl
type
label
Comparison of 3′-deoxy-3′-[18F ...... rization of pancreatic tumours
@en
Comparison of 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography
@nl
prefLabel
Comparison of 3′-deoxy-3′-[18F ...... rization of pancreatic tumours
@en
Comparison of 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography
@nl
P2093
P2860
P50
P1476
Comparison of 3'-deoxy-3'-[¹⁸F ...... rization of pancreatic tumours
@en
P2093
H J Wester
J T Siveke
K Herrmann
R M Schmid
T Schuster
P2860
P2888
P304
P356
10.1007/S00259-012-2061-8
P577
2012-01-26T00:00:00Z